Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells

Neuropeptides

Volumn 43, Issue 5, 2009, Pages 387-396

  Falktoft, Birgitte ^a   Georg, Birgitte ^a   Fahrenkrug, Jan ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CREB; ERK; FOS; Gene expression; PACAP; Phosphorylation; Protein kinase; Signaling; VIP

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ACTIVATING TRANSCRIPTION FACTOR 1; BISINDOLYLMALEIMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MAXADILAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN FOS; PROTEIN KINASE C; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GANGLION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INNERVATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; NEUROBLASTOMA; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 70350127952     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.08.002     Document Type: Article

References (55)

1. Abrahamson E.E., and Moore R.Y. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res. 916 (2001) 172-191
2. Adler E.M., and Fink J.S. Calcium regulation of vasoactive intestinal polypeptide mRNA abundance in SH-SY5Y human neuroblastoma cells. J. Neurochem. 61 (1993) 727-737
3. Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D.D., and Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell Biol. 18 (1998) 967-977
4. Aton S.J., Colwell C.S., Harmar A.J., Waschek J., and Herzog E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat. Neurosci. 8 (2005) 476-483
5. Aubert N., Falluel-Morel A., Vaudry D., Xifro X., Rodriguez-Alvarez J., Fisch C., de Jouffrey S., Lebigot J.F., Fournier A., Vaudry H., and Gonzalez B.J. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. J. Neurochem. 99 (2006) 1237-1250
6. Braas K.M., Schutz K.C., Bond J.P., Vizzard M.A., Girard B.M., and May V. Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons. Peptides 28 (2007) 1856-1870
7. Butch E.R., and Guan K.L. Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2. J. Biol. Chem. 271 (1996) 4230-4235
8. Cauvin A., Buscail L., Gourlet P., De Neef P., Gossen D., Arimura A., Miyata A., Coy D.H., Robberecht P., and Christophe J. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 11 (1990) 773-777
9. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
10. i and inositol phosphates in human neuroblastoma NB-OK-1 cells. Peptides 14 (1993) 1111-1118
11. Dickson L., Aramori I., McCulloch J., Sharkey J., and Finlayson K. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacology 51 (2006) 1086-1098
12. Dickson L., and Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol. Ther. 121 (2009) 294-316
13. Dumaz N., and Marais R. Integrating signals between cAMP, the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie lecture delivered on 5 July at the special FEBS meeting in Brussels. FEBS J. 272 (2003) 3491-3504
14. Evangelopoulos M.E., Weis J., and Krüttgen A. Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 24 (2005) 3309-3318
15. Fahrenkrug J. PACAP - a multifaceted neuropeptide. Chronobiol. Int. 23 (2006) 53-61
16. Falktoft B., Georg B., and Fahrenkrug J. Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells. Neuropeptides 43 (2009) 53-61
17. Fukuchi M., Sakuragawa S., Tabuchi A., and Tsuda M. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells. J. Neurosci. Res. 77 (2004) 26-34
18. Georg B., and Fahrenkrug J. Pituitary adenylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells. Brain Res. Mol. Brain Res. 79 (2000) 67-76
19. Georg B., Hannibal J., and Fahrenkrug J. Lack of the PAC1 receptor alters the circadian expression of VIP mRNA in the suprachiasmatic nucleus of mice. Brain Res. 1135 (2007) 52-57
20. Gerhold L.M., Sellix M.T., and Freeman M.E. Antagonism of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus disrupts the rhythm of FRAs expression in neuroendocrine dopaminergic neurons. J. Comp. Neurol. 450 (2002) 135-143
21. Girard B.M., May V., Bora S.H., Fina F., and Braas K.M. Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction. Regul. Pept. 109 (2002) 89-101
22. Girard B.A., Lelievre V., Braas K.M., Razinia T., Vizzard M.A., Ioffe Y., El Meskini R., Ronnett G.V., Waschek J.A., and May V. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. J. Neurochem. 99 (2006) 499-513
23. Hahm S.H., and Eiden L.E. Cis-regulatory elements controlling basal and inducible VIP gene transcription. Ann. NY Acad. Sci. 865 (1998) 0-26
24. Hahm S.H., and Eiden L.E. Two separate cis-active elements of the vasoactive intestinal peptide gene mediate constitutive and inducible transcription by binding different sets of AP-1 proteins. J. Biol. Chem. 274 (1999) 25588-25593
25. Hamelink C., Lee H.W., Chen Y., Grimaldi M., and Eiden L.E. Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J. Neurosci. 22 (2002) 5310-5320
26. Hamelink C., Lee H.W., Hsu C.M., and Eiden L.E. Role of protein kinases in neuropeptide gene regulation by PACAP in chromaffin cells: a pharmacological and bioinformatic analysis. Ann. NY Acad. Sci. 971 (2002) 474-490
27. Hamelink C., Hahm S.H., Huang H., and Eiden L.E. A restrictive element 1 (RE-1) in the VIP gene modulates transcription in neuronal and non-neuronal cells in collaboration with an upstream tissue specifier element. J. Neurochem. 88 (2004) 1091-1101
28. Hannibal J., and Fahrenkrug J. Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas. Cell Tissue Res. 299 (2000) 59-70
29. Hannibal J., Jamen F., Nielsen H.S., Journot L., Brabet P., and Fahrenkrug J. Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J. Neurosci. 21 (2001) 4883-4890
30. Hannibal J., and Fahrenkrug J. Melanopsin containing retinal ganglion cells are light responsive from birth. Neuroreport 15 (2004) 2317-2320
31. Hannibal J. Roles of PACAP-containing retinal ganglion cells in circadian timing. Int. Rev. Cytol. 251 (2006) 1-39
32. Hipskind R.A., and Nordheim A. Functional dissection in vitro of the human c-fos promoter. J. Biol. Chem. 266 (1991) 19583-19592
33. Johannessen M., and Moens U. Multisite phosphorylation of the cAMP response element-binding protein (CREB) by a diversity of protein kinases. Front. Biosci. 12 (2007) 1814-1832
34. Kalamatianos T., Kalló I., Piggins H.D., and Coen C.W. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites. J. Comp. Neurol. 475 (2004) 19-35
35. Kawaguchi C., Tanaka K., Isojima Y., Shintani N., Hashimoto H., Baba A., and Nagai K. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem. Biophys. Res. Commun. 310 (2003) 169-175
36. Laburthe M., Couvineau A., and Tan V. Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology. Peptides 28 (2007) 1631-1639
37. Liu D., Krajniak K., Chun D., Sena M., Casillas R., Lelièvre V., Nguyen T., Bravo D., Colburn S., and Waschek J.A. VIP gene transcription is regulated by far upstream enhancer and repressor elements. Biochem. Biophys. Res. Commun. 284 (2001) 211-218
38. Lutz E.M., Ronaldson E., Shaw P., Johnson M.S., Holland P.J., and Mitchell R. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol. Cell Neurosci. 31 (2006) 193-209
39. Moreno D., Gourlet P., De Neef P., Cnudde J., Waelbroeck M., and Robberecht P. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor. Peptides 21 (2000) 1543-1549
40. Moro O., and Lerner E.A. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J. Biol. Chem. 272 (1997) 966-970
41. Mulderry P.K. Synergistic regulation of vasoactive intestinal polypeptide expression by cyclic AMP and calcium in newborn but not adult rat sensory neurons in culture. Neuroscience 53 (1993) 229-238
42. Pellegrino M.J., and Stork P.J. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J. Neurochem. 99 (2006) 1480-1493
43. Pisegna J.R., and Wank S.A. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J. Biol. Chem. 271 (1996) 17267-17274
44. Ravni A., Eiden L.E., Vaudry H., Gonzalez B.J., and Vaudry D. Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J. Neurochem. 98 (2006) 1229-1241
45. Robberecht P., Gourlet P., De Neef P., Woussen-Colle M.C., Vandermeers-Piret M.C., Vandermeers A., and Christophe J. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur. J. Biochem. 207 (1992) 239-246
46. Sanggaard K.M., Hannibal J., and Fahrenkrug J. Serotonin inhibits glutamate- but not PACAP-induced per gene expression in the rat suprachiasmatic nucleus at night. Eur. J. Neurosci. 17 (2003) 1245-1252
47. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., and Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365 (1993) 170-175
48. Sumner A.D., and Margiotta J.F. Pituitary adenylate cyclase-activating polypeptide (PACAP) alters parasympathetic neuron gene expression in a time-dependent fashion. J. Mol. Neurosci. 36 (2008) 141-156
49. Sun Y., Rao M.S., Landis S.C., and Zigmond R.E. Depolarization increases vasoactive intestinal peptide- and substance P-like immunoreactivities in cultured neonatal and adult sympathetic neurons. J. Neurosci. 12 (1992) 3717-3728
50. Symes A., Lewis S., Corpus L., Rajan P., Hyman S.E., and Fink J.S. STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines. Mol. Endocrinol. 8 (1994) 1750-1763
51. 2+ channel activation regulates c-fos transcription at multiple levels. J. Biol. Chem. 270 (1995) 4224-4235
52. Tornøe K., Hannibal J., Jensen T.B., Georg B., Rickelt L.F., Andreasen M.B., Fahrenkrug J., and Holst J.J. PACAP-(1-38) as neurotransmitter in the porcine adrenal glands. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1413-1425
53. Vaudry D., Basille M., Anouar Y., Fournier A., Vaudry H., and Gonzalez B.J. The neurotrophic activity of PACAP on rat cerebellar granule cells is associated with activation of the protein kinase A pathway and c-fos gene expression. Ann. NY Acad. Sci. 865 (1998) 92-99
54. Vaudry D., Chen Y., Ravni A., Hamelink C., Elkahloun A.G., and Eiden L.E. Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem. 83 (2002) 1272-1284
55. Yang S.H., Sharrocks A.D., and Whitmarsh A.J. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320 (2003) 3-21